Selected article for: "cause mortality and clinical study"

Author: López, Jesús Manuel Morán
Title: Malnutrition and nutritional support in COVID-19: outcome of a rational nutritional support protocol
  • Cord-id: dqr57p20
  • Document date: 2021_3_30
  • ID: dqr57p20
    Snippet: INTRODUCTION: COVID-19 is characterized by various clinical manifestations, mainly respiratory involvement. Disease-related malnutrition is associated with impaired respiratory function and increased all-cause morbidity and mortality. Patients with COVID-19 infection carry a high nutritional risk. After designing a specific nutritional support protocol for this disease, we carried out a retrospective study on malnutrition and on the use of nutritional support in patients with COVID-19. METHODS:
    Document: INTRODUCTION: COVID-19 is characterized by various clinical manifestations, mainly respiratory involvement. Disease-related malnutrition is associated with impaired respiratory function and increased all-cause morbidity and mortality. Patients with COVID-19 infection carry a high nutritional risk. After designing a specific nutritional support protocol for this disease, we carried out a retrospective study on malnutrition and on the use of nutritional support in patients with COVID-19. METHODS: We performed a retrospective study to determine whether nutritional support positively affected hospital stay, clinical complications, and mortality in patients with COVID-19. We compared the results with those of standard nutritional management. Our secondary objectives were to determine the prevalence of malnutrition in patients with COVID-19 and the value of nutritional support in the hospital where the study was performed. RESULTS: At least 60% of patients with COVID-19 experience malnutrition (up to 78.66% presented at least 1 of the parameters studied). The specialized nutritional support protocol was indicated in only 21 patients (28%) and was started early in only 12 patients (16%). Hospital stay was significantly shorter in patients managed with the early protocol (5.09 days, 95% CI, 1.338–8.853, p<0.01). Similarly, in this group, respiratory distress was less severe and less frequent (41% vs 82.5%, p<0.007), and statistically significantly fewer complications were recorded (9/12 vs 91/63; p<0.001). CONCLUSIONS: COVID-19 is associated with high rates of disease-related malnutrition. Early implementation of a specialized nutritional support plan can improve the prognosis of these patients by reducing hospital stay, the possibility of more severe respiratory distress, and complications in general.

    Search related documents:
    Co phrase search for related documents
    • acute inflammation and lopinavir ritonavir: 1, 2, 3, 4, 5
    • acute inflammation and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute inflammation and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • admission admission and lopinavir ritonavir: 1, 2
    • admission admission and lung function: 1, 2
    • admission admission and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • admission duration and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
    • admission duration and lung function: 1, 2
    • admission duration and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission value and lopinavir ritonavir: 1
    • admission value and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • lopinavir ritonavir and low number: 1
    • lopinavir ritonavir and lung function: 1, 2, 3, 4, 5
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • low degree and lung function: 1, 2
    • low number and lung function: 1
    • low number and lymphocyte count: 1, 2, 3
    • lung function and lymphocyte count: 1, 2, 3, 4, 5, 6